{"metadata":{"topics":["Accountability","Administrative law","Anti-competitive behaviour","Applications of cryptography","Applied ethics","Arbitration","Artificial objects","Asset","Attorney's fee","Brand management","Budget","Bupivacaine","Business","Business law","Case law","Cause of action","China","Choice of law","Civil law (common law)","Civil law (legal system)","Civil procedure","Civil rights and liberties","Clinical pharmacology","Clinical research","Clinical trial","Clinical trials","Cognition","Cognitive science","Common law","Communication","Communication design","Companies","Comparative law","Competition (economics)","Computer law","Computer security","Computing","Confidentiality","Conflict (process)","Constitutional law","Contract law","Control (social and political)","Controversies","Corporate law","Corporate personhood","Corporation","Corporations","Cost","Courts","Crime","Crime prevention","Criminal justice","Criminal law","Cultural globalization","Cultural politics","Culture","Cyberspace","Damages","Data","Data laws","Deadlock","Decision-making","Definition","Dispute resolution","Doctrines","Documents","Dosage form","Drug development","Drug discovery","Drugs","Economic sectors","Economics of regulation","Economy","Email","Entity","Environmental law","Epistemology","Ethical principles","Ethically disputed business practices","Ethics","European Union","Evidence","Evidence-based practices","Exclusive right","Executive branch of the United States government","Existence","Facsimile","Fax","Finance","Financial markets","Foreign policy","Freedom of expression","Global politics","Good faith","Government","Government agencies","Government and personhood","Government information","Government institutions","Government of South Africa","Government of the United States","Government-related organizations","Health","Health care","Health economics","Health policy","Health research","Health sciences","Healthcare industry","Healthcare management","Healthcare quality","Hong Kong","Human activities","Human rights","Identification","Identity politics","Imperfect competition","Indemnity","India","Individualism","Indonesia","Industries","Industry","Information","Information Age","Information and communications technology","Information governance","Information science","Information technology","Information technology management","Intangible assets","Intellectual property law","Intellectual works","International law","International relations","Judiciaries","Jurisdiction","Jurisprudence","Justice","Justification","Know-how","Law","Law and economics","Law enforcement","Law enforcement techniques","Law of obligations","Lawsuits","Lawyer","Legal action","Legal concepts","Legal disputes","Legal doctrines and principles","Legal documents","Legal ethics","Legal fictions","Legal literature","Legal procedure","Legal writing","Libertarian theory","License","Licenses","Life sciences","Life sciences industry","Love","Malaysia","Management","Manufacturing","Market (economics)","Marketing","Matter","Media freedom","Medical ethics","Medical humanities","Medical research","Medical treatments","Medication","Medicinal chemistry","Medicine","Metaphysics","Microeconomics","Monopoly (economics)","Morality","Names","National security","Natural resources law","New York (state)","New York City","Non-disclosure agreement","Official documents","Open government","Ownership","Patient","Patient safety","Payment","Percentage","Personality traits","Pharmaceutical industry","Pharmaceutical sciences","Pharmaceutics","Pharmacology","Pharmacy","Philippines","Philosophical movements","Philosophical theories","Philosophy","Political economy","Political ideologies","Political science","Political theories","Politics","Politics of the United States","Practical philosophy","Practice of law","Preamble","Prevention","Principle","Principles","Privacy","Privacy law","Private law","Product","Production and manufacturing","Professional ethics","Property","Property law","Public administration","Public health","Public law","Public policy","Public records","Public services","Public sphere","Quality","Quality control","Regulation","Research","Rights","Roman law","Royalty-free","Rules","Safety","Science","Secrecy","Securities (finance)","Security","Security (finance)","Separation of powers","Service industries","Services (economics)","Signature","Singapore","Social ethics","Social information processing","Social institutions","Social issues","Sociological theories","Sole proprietorship","Sources","South African law","Statutory law","Stereotypes","Supply chain management","Supreme court case law","Symbols","Taiwan","Technology","Telecommunications law","Telephone","Thailand","Theories of law","Theory of medicine","Therapy","Trademark","Trademarks","Trial","Truth","U.S. Securities and Exchange Commission","United States","United States federal case law","United States federal law","United States federal policy","United States law","United States lawsuits","Value (ethics)","Venezuela","Vietnam","Virtue","Witness","Written communication"],"person_names":["durect","durect corporation      nycomed","durect corporation      nycomed danmark","nycomed","nycomed danmark","post-registration plan"],"vars":{},"organization_names":["development data","durect","eu cdp","jdc","jdp budget","jec","notification","nycomed danmark aps","regulatory approval","trademark department  facsimilie"],"agreement_id":"c7d7ca03ef2988c97717f4a9cebe50986ecbb2b6f931cacb96220181d5c41502","terms":["* *","**DURECT**","**NYCOMED**","*]      [*","*] NYCOMED shall have the right to terminate this Agreement without cause by giving [*","*] [*","*] by a date no later than [*","“Agreement”","“Amendment Date”","“Amendment No. 1”","“Clinical Trial Supplies”","“DURECT”","“Development Costs”","“Development Program”","“JDP Budget”","“NYCOMED”","“Notification”"]}}